Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT00667667
Other study ID # OFZ-Elvis-II
Secondary ID
Status Terminated
Phase Phase 3
First received April 24, 2008
Last updated May 27, 2015
Start date April 2008
Est. completion date November 2009

Study information

Verified date May 2015
Source University of Erlangen-Nürnberg Medical School
Contact n/a
Is FDA regulated No
Health authority Germany: Federal Institute for Drugs and Medical DevicesGermany: Federal Ministry of Education and Research
Study type Interventional

Clinical Trial Summary

There is general agreement that physical exercise can positively influence osteoporotic fracture risk along two pathways: first by reducing the risk of falls via an improvement of fall related neuromuscular abilities; second by increasing bone strength.

Whole body vibration (WBV) training has recently been proposed as a new approach for prevention and treatment of osteoporosis. Animal studies have shown evidence that WBV may be an effective method to improve bone mass, architecture and strength. However, the results of human WBV training studies are rather heterogeneous.

In the Erlangen Longitudinal Vibration Study II (ELVIS II), a randomized, controlled 12 month lasting study the investigators determine the effect of a thrice weekly WBV training on two different devices on the osteoporotic risk factors: bone mineral density, falls and neuromuscular performance. Particular the investigators compare a bipedal vertical oscillating Plate with a plate which rotates around a central axis leading to a side-alternating loaning.


Recruitment information / eligibility

Status Terminated
Enrollment 108
Est. completion date November 2009
Est. primary completion date June 2009
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 60 Years to 75 Years
Eligibility Inclusion Criteria:

- females 60 - 75 years old

- caucasian race

Exclusion Criteria:

- CHD-diseases

- thrombosis, embolism

- fractures at lumbar spine or hip

- secondary osteoporosis

- hyperparathyroidism

- medication, diseases with impact on muscle or bone

- hip or knee implant

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Device:
vertical vibration device (Vibrafit whole body vibration platform)
3 sessions/week 15 min each, leg exercises performed on whole body vibration platforms with vertical device
side alternating vibration device (Board 3000 whole body vibration platform)
3 sessions/week 15 min each, leg exercises performed on whole body vibration platforms with side alternating device
Behavioral:
stretching and wellness (control group)
2x10 weeks with 1 session/week of low volume, low intensity wellness training over 12 months

Locations

Country Name City State
Germany Institute of Medical Physics, University of Erlangen-Nurnberg Erlangen

Sponsors (2)

Lead Sponsor Collaborator
University of Erlangen-Nürnberg Medical School Elsbeth-Bonhoff-Stiftung, Berlin

Country where clinical trial is conducted

Germany, 

References & Publications (3)

Kemmler W, Lauber D, Weineck J, Hensen J, Kalender W, Engelke K. Benefits of 2 years of intense exercise on bone density, physical fitness, and blood lipids in early postmenopausal osteopenic women: results of the Erlangen Fitness Osteoporosis Prevention Study (EFOPS). Arch Intern Med. 2004 May 24;164(10):1084-91. — View Citation

Stengel SV, Kemmler W, Pintag R, Beeskow C, Weineck J, Lauber D, Kalender WA, Engelke K. Power training is more effective than strength training for maintaining bone mineral density in postmenopausal women. J Appl Physiol (1985). 2005 Jul;99(1):181-8. Epub 2005 Mar 3. — View Citation

von Stengel S, Kemmler W, Kalender WA, Engelke K, Lauber D. Differential effects of strength versus power training on bone mineral density in postmenopausal women: a 2-year longitudinal study. Br J Sports Med. 2007 Oct;41(10):649-55; discussion 655. Epub 2007 Jun 5. Erratum in: Br J Sports Med. 2007 Dec;41(12):926. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Bone Mineral Density Baseline, 12 months No
Secondary muscle strength baseline, 12 months No
Secondary Quality of life baseline, 12 month No
Secondary falls daily over 12 month No
See also
  Status Clinical Trial Phase
Completed NCT02235051 - Exercise Intervention in Preventing Breast Cancer Recurrence in Postmenopausal Breast Cancer Survivors N/A
Completed NCT01635413 - Group Exercise Training for Functional Improvement After Treatment (The GET FIT Trial) N/A
Completed NCT00701337 - Effect of 17ß-estradiol on Inflammatory-immune Responses in Post-menopausal Women According to Administration Route Phase 4
Recruiting NCT04705623 - Influence of Iyengar Yoga on the Bio-functional Age of Postmenopausal Women N/A
Withdrawn NCT03238703 - Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer Phase 4
Completed NCT03756272 - Stellate Ganglion Block to Reduce Hot Flushes N/A
Recruiting NCT03953157 - Dietary and Exercise Interventions in Reducing Side Effects in Patients With Stage I-IIIa Breast Cancer Receiving Aromatase Inhibitors N/A
Completed NCT00338728 - Letrozole and Imatinib Mesylate in Treating Postmenopausal Participants With Estrogen or Progesterone Positive Metastatic Breast Cancer Phase 2
Completed NCT01482702 - Impact of Weight Loss Interventions for Overweight Breast Cancer Survivors N/A
Not yet recruiting NCT05009238 - Effect of l S Exercises on Balance and Spatiotemporal Gait Parameters in P M Women N/A
Terminated NCT01842217 - Validation of [18F]FES for Imaging of Brain Estrogen Receptors N/A
Completed NCT01172574 - Motor Control Exercise in Osteoporotic Women N/A
Completed NCT00530582 - Progesterone Reduces Wakefulness in Sleep EEG and Has no Effect on Cognition in Healthy Postmenopausal Women Phase 4
Completed NCT01825785 - A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Romosozumab (AMG 785) Phase 1
Completed NCT04364061 - Post Exercise Substrate Oxidation, Appetite and Energy Intakes in Overweight/Obese Postmenopausal Women (EScAPE) N/A
Completed NCT03180294 - Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer Phase 2
Recruiting NCT06445842 - Short-term Circuit Training on Muscle Mass and Quality of Life in Sedentary Postmenopausal Women N/A
Completed NCT01753908 - Broccoli Sprout Extract in Treating Patients With Breast Cancer Early Phase 1
Not yet recruiting NCT06377631 - Effect of Multi-ingredient on Visceral Adiposity & Non-alcoholic Fatty Liver Disease in Postmenopausal Women With Abdominal Obesity N/A
Recruiting NCT06228768 - Acupressure for Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Patients With Breast Cancer N/A